fwiw...from Ariad 2000 annual report, just
poking around at Tularik etc.
Competition
The field of gene-based drug discovery is new and rapidly evolving, and we expect that it will continue to undergo significant technological change. We anticipate that we will experience intense competition from other companies in the gene therapy and genomics fields and those that are developing small-molecule drugs that target signal transduction pathways. We are aware of many early-stage
and established companies, including major pharmaceutical and biotechnology firms, that are pursuing the development of gene-based drugs or are actively engaged in gene therapy. Companies in the gene therapy field include Avigen, Inc., Biogen, Inc., Cell Genesys, Inc., GenVec, Inc., Genzyme Corp., Targeted Genetics Corp., TransGene S.A., and Valentis, Inc. However, we do not believe that any of these companies has started clinical
development of regulated gene therapy products. We are aware of several companies that are developing specific products to treat GvHD, including Abgenix, Inc., AVAX, Inc., BioTransplant, Inc., Protein Design Labs, Inc. and Repligen Corp. We may also experience competition from companies that have acquired or may acquire technology from companies, universities, and other research institutions. As these companies develop their technologies, they may develop proprietary positions which may materially and adversely affect us. In the area of signal transduction inhibitors, companies such as AstraZeneca plc, Biogen, Inc., Ligand Pharmaceuticals, Inc., Novartis Pharma AG, OSI Pharmaceuticals, Inc., Pharmacia, Inc., Tularik, Inc., and Vertex Pharmaceuticals, Inc. are developing drugs to treat human disease by regulating genes and inhibiting signal transduction pathways.
Probably not a complete list, but thought I'd post it.
If Rick likes Tularik, well then it is probably worth a
look. I wonder if Tularik is at risk of being bought up,
that seems to be in the headlines these days after imnx.
Geeze, NVS, 93 Billion marketcap.
I just cant bring myself to do those. |
